1. Home
  2. BTOC vs ATNM Comparison

BTOC vs ATNM Comparison

Compare BTOC & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.58

Market Cap

43.6M

Sector

N/A

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.68

Market Cap

47.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
ATNM
Founded
2020
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.6M
47.1M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
BTOC
ATNM
Price
$0.58
$1.68
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
101.0K
170.6K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$197,399,541.00
$90,000.00
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
$42,943.57
P/E Ratio
N/A
N/A
Revenue Growth
17.35
11.11
52 Week Low
$0.41
$1.03
52 Week High
$5.40
$2.41

Technical Indicators

Market Signals
Indicator
BTOC
ATNM
Relative Strength Index (RSI) 41.70 65.09
Support Level $0.60 $1.48
Resistance Level $0.69 $1.69
Average True Range (ATR) 0.05 0.10
MACD -0.00 0.03
Stochastic Oscillator 16.96 97.33

Price Performance

Historical Comparison
BTOC
ATNM

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: